Should Oxytocin Be a Daily Part of Your Bioidentical Hormone Replacement Program?

Oxytocin is often used when needed to improve intimacy. Research shows oxytocin can help control obesity, type 2 diabetes, prevent and reverse osteoporosis, rebuild and maintain muscle mass, reduce chronic pain, and regenerate neurons. Should oxytocin be used daily as part of bioidentical hormone replacement therapy (BHRT)? Oxytocin is often described as the “hug hormone,”… Continue reading Should Oxytocin Be a Daily Part of Your Bioidentical Hormone Replacement Program?

Green Medicine—Full October PDF Edition

If you would like to download and print a pdf version of Green Medicine, you can do so here. Now you can take Green Medicine wherever you go. If you do not have Adobe Reader, please download here. In this issue, an extended article: Should Oxytocin Be a Daily Part of Your Bioidentical Hormone Replacement Program?

Frankenbroccoli for Dinner?

Organic products are at risk. Action Alert! When consumers purchase organic produce, they expect to avoid vegetables and fruits that have been genetically modified or sprayed with dangerous pesticides. The unsettling reality, however, is that cross-contamination between GM plants and conventional or organic plants is not only possible—it is already happening. Take the example of… Continue reading Frankenbroccoli for Dinner?

EPA Scientists Are Not Dumb

Their political and industry bosses must have told them what to say. Action Alert! The US Environmental Protection Agency (EPA) recently released a draft report finding that glyphosate—the active ingredient in Monsanto’s popular Roundup weed killer—is not likely to cause cancer in humans. This finding is preliminary, to be followed by the agency’s final review of glyphosate,… Continue reading EPA Scientists Are Not Dumb

FDA Tries to Run Out Clock on Bill to Help Dying Patients

New federal legislation offers dying patients new hope. It needs our support. Action Alert! The legislation, introduced by Sen. Ron Johnson (R-WI), would prohibit the federal government, particularly the US Food and Drug Administration, from blocking patient access to experimental medications. FDA Commissioner Robert Califf was scheduled to attend a hearing on the bill, but… Continue reading FDA Tries to Run Out Clock on Bill to Help Dying Patients